respiratory disease - HealthQuill

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

A patient in Northern Arizona, US, has died from pneumonic plague, the first such death in the country since 2007, according to a government statement.

Northern Arizona resident dies of pneumonic plague, first since 2007

HQ Team July 13, 2025: A patient in Northern Arizona, US, has died from pneumonic plague, the first such death in the country.

by HealthQuill
July 13, 2025
0 Comments

Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.

Drugs Health

New treatment for severe asthma attacks in 50 years

Bharti Jayshankar November 29, 2024: Around half a billion people live with asthma and chronic obstructive pulmonary disease (COPD). The Global Burden of.

by HealthQuill
November 29, 2024
0 Comments

British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy to treat older adults during a phase III stage trial.

Drugs Health Pharma

GSK’s RSV vaccine shows positive data on efficacy in older adults

HQ Team June 21, 2023: British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy.